Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeuroBo Pharmaceuticals, Inc. - Common Stock (NQ:NRBO)

2.360 UNCHANGED
Last Price Updated: 3:59 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about NeuroBo Pharmaceuticals, Inc. - Common Stock

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
Via ACCESSWIRE
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Investor Forum Agenda Announced for November 14th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
NeuroBo Pharmaceuticals to Present at the November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) is One of Thursday Morning’s Most Active Stocks
Via Investor Brand Network
Exposures COVID-19
Life Science Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
The Center for Advancing Innovation's Board Member, Gil Price, Realizes Turn Around in Less than 12 Months
The Center for Advancing Innovation’s Board Member, Gil Price, Realizes Turn Around in Less than 12 Months - IssueWire 
Via IssueWire
Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MACK),(NASDAQ:NRBO),(NYSE:MRK),(NASDAQ:RNAZ), EQNX::TICKER_END 
Via FinancialNewsMedia
Accelerating R&D Activities in Breast Cancer Therapy Market Fueling Optimism for Development of Advanced Treatments
Palm Beach, FL – October 14, 2021 – FinancialNewsMedia.com News Commentary – The breast cancer drugs market, which has been steadily growing over the past few years, is projected to continue this trend... 
Via FinancialNewsMedia
Exposures COVID-19
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.